MGC Pharmaceuticals to buy Australia’s top medicinal cannabis clinic
By Nikita Chaurasia  Date: 2020-07-20

MGC Pharmaceuticals to buy Australia’s top medicinal cannabis clinic

As reported by credible sources, MGC Pharmaceuticals Ltd, a European bio-pharma firm, aims to acquire the complete data, intellectual property, and operating clinic-based assets of Medicinal Cannabis Clinic Pty Ltd.

As per the agreement, the new company, which will be incorporated to hold all assets of MCC, will attain pertinent state and federal licenses. This permit will further enable the import and supply of medicinal cannabis products. The company would be able to offer inexpensive cannabinoid through the focused reduction of import, storage, and distribution costs per unit.

For those uninitiated, MGC Pharma specializes in production and development of medicines which are EU-GMP Phyto cannabinoid derived. It has signed an agreement with Cannvalate Pty Ltd in a bid to acquire its wholly owned subsidiary MCC, which s has an extensive network of patients and doctors.

Speaking of the move, co-founder & MD of MGC Pharma, said that the acquisition of MCC assets is a vital part of their strategy to expand their direct supply chain capabilities and distribution network in Australia, and world over. He further added that the organization will achieve its cashflow breakeven goals through this acquisition. The company looks forward to integrating high-quality clinics network of MCC, he said.

MGC Pharma has reportedly decided to continue services of MCC staff to maintain the continuity of operations of the new firm, ensuring exceptional clinical governance and independence. The fundamental business ethos, product offering, and existing operations of MCC will remain unchanged.

If reports are to be believed, the deal includes USD 400,000 in cash and USD 1 million in MGC Pharma shares. The clearance of the transaction is projected to be concluded within 90 days.

Source- https://www.proactiveinvestors.com.au/companies/news/924532/mgc-pharmaceuticals-moves-to-acquire-one-of-australia-s-leading-medicinal-cannabis-clinics-924532.html

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Mercedes-Benz unveils the EQA SUV in a bid to outdo Tesla, Volkswagen
Mercedes-Benz unveils the EQA SUV in a bid to outdo Tesla, Volkswagen
By Nikita Chaurasia

Daimler AG owned German automotive giant, Mercedes-Benz, has reportedly introduced the EQA, a new electric compact SUV to compete with market leader Tesla, Inc. as well as to meet its carbon targets in China and Europe. The Mercedes-Benz EQA, one of...

New York planning on direct purchase of Pfizer’s COVID-19 vaccines
New York planning on direct purchase of Pfizer’s COVID-19 vaccines
By Nikita Chaurasia

In recent developments, Governor of New York, Andrew Cuomo has reportedly issued a letter to the CEO of American drug maker Pfizer Inc., Albert Bourla, requesting for direct purchase of COVID-19 vaccine doses. Although the company is not bound to any...

Mayo Clinic Laboratories forms alliance with American Hospital Dubai
Mayo Clinic Laboratories forms alliance with American Hospital Dubai
By Nikita Chaurasia

In recent developments, Minnesota-based Mayo Clinic Laboratories and American Hospital Dubai are reportedly planning on entering a strategic alliance which is aimed at enhancing advanced laboratory diagnostic services in Dubai. Under the terms of th...

LTI, IBM extend global partnership to spearhead digital transformation
LTI, IBM extend global partnership to spearhead digital transformation
By Nikita Chaurasia

The New York-headquartered IBM Corp., with its global partner Larsen Toubro Infotech, an Indian global IT solutions & services company, are planning to extend their multi-year partnership, in a bid to enable companies to revolutionize the busines...

Algae cultivator Qualitas Health raises USD 10 million in funding round
Algae cultivator Qualitas Health raises USD 10 million in funding round
By Nikita Chaurasia

In recent developments, privately held food and nutrition company Qualitas Health Inc. has reportedly secured USD 10 million in venture funds, as it looks to broaden the reach of its plant-based protein and omega-3 business. The company was appraised...